drugset
drugset / Trial / NCT00484029

Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain

NCT00484029 ↗

Phase 2 Completed 100 enrolled Capnia, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This purpose of this study is to evaluate the safety and efficacy of treatment with nasal CO2 in the treatment of pain and other symptoms related to temporomandibular disorder (TMD).

Timeline

Start
2007-02
Primary completion
2008-10
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject carbon dioxide Other / unclassified — Intranasal

Indications

headache disorder temporomandibular joint disorder